Canada’s Intellectual Property Firm

Health Canada Annual Drug Submission Performance Reports released

Authored byBrandon Heard

Update: On September 1, 2020, BRDD revised its Report to correct the “Biosimilars: Market Authorizations” tables.

The Therapeutic Products Directorate (TPD), the Biologic and Radiopharmaceutical Drugs Directorate (BRDD; formerly BGTD) and the Natural and Non-Prescription Health Products Directorate (NNHPD) have released their Drug Submission Performance Annual Reports for Fiscal Year 2019-2020. The reports contain information regarding pharmaceutical, biologic and radiopharmaceutical, and non-prescription and disinfectant drug submission review activity over five consecutive fiscal years (April 1 to March 31) from 2015-2016 to 2019-2020.